Number: 2 / Year: 2021

Gene Editing

Editor : Fatih Kocabaş, Cihan Taştan
Publication Place : İstanbul, Türkiye
Year-Number : 2021 - 2

Articles for this issue

1 Review Article
Gene Therapy Products Reached to Market by 2021 , 1-21
http://dx.doi.org/10.29228/genediting.54101
Sümbül Yıldırım -Fatih Kocabaş
2 Research Article
Development of Gene Editing Strategies for CCR5 Gene in Endothelial Cells , 22-30
http://dx.doi.org/10.29228/genediting.54872
Sezer Akgöl -Ecren Yetim -Batuhan Mert Kalkan -Fatih Kocabaş
3 Review Article
Diagnosis and Treatment of Fanconi Anemia: Special Focus on Nuclease-Mediated Gene Therapy , 31-35
http://dx.doi.org/10.29228/genediting.54091
Medine Karadağ-Alpaslan -Cansu Can
4 Research Article
The Development of Recombinant hSpCas9 Production System in E. coli , 36-43
http://dx.doi.org/10.29228/genediting.54955
Merve Uslu -Esra Serasker -Fatih Kocabaş
5 Research Article
Development of CXCR4 Gene Editing in Human Umbilical Vein Endothelial Cells Using the CRISPR/CAS9 System , 44-49
http://dx.doi.org/10.29228/genediting.54939
Sezer Akgöl -Ecren Yetim -Fatih Kocabaş
6 Review Article
The Effect Of Molecular Genetic Mechanisms On Drug Addiction And Related New Generation CRISPR Gene Engineering Applications , 50-60
http://dx.doi.org/10.29228/genediting.54941
Ebru Akyürek -Buket Uysal -Gamze Gülden -Cihan Taştan